Piramal Pharma Shares Jump 14% as FY27 Revenue Growth Outlook Rises to 20%
Shares rose 14% after Piramal Pharma returned to quarterly profitability, more than doubled operating earnings and raised its FY27 revenue growth outlook. Its CDMO business revenue increased year on year to Rs 1,424 crore from Rs 1,044 crore.